Health Care Costs
ASCO Roundtable Addresses Clinical Trial Financial Burdens
September 25, 2018The American Society of Clinical Oncology hosted a roundtable to develop recommendations targeted at improving patients' out-of-pocket costs for clinical trial participation.
Poor, Non-English Speaking Cancer Patients Need Support
September 07, 2018Non-English speaking and uninsured patients with cancer may require additional support systems, such as referral to socioeconomic support, for best care.
Assessing Direct Costs of Treatment-Related Adverse Events in Advanced Melanoma
August 10, 2018In a systematic review, researchers explored the financial burden of treating grade 3 to 4 adverse events associated with melanoma and its treatment.
Healthcare Use, Economic Burden Greater With Cancer-Related Opioid-Induced Constipation
August 03, 2018Use of opioids to manage cancer-related pain may have adverse effects of its own that can have a significant impact on healthcare use among patients with cancer.
Financial Toxicity Discussions an Unmet Need for Breast Cancer Patients
July 24, 2018Survey responses revealed that clinicians and patients do not agree on whether discussions regarding the impact of treatment on employment and/or financial status occur or are helpful.
Younger Patients, Higher Costs: The Changing Demographics of Cancer
June 27, 2018This overview provides a snapshot of the shift in cancer care costs and age of patients, reviewing the 4 most commonly diagnosed cancers.
The Health Care Mortgage: Understanding the Complexities of Financial Toxicity
June 15, 2018Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
Intervention With Lay Health Workers Has Positive Effect on Cancer Patients' Experience
June 06, 2018An intervention utilizing lay health workers supervised by NPs lowered health care costs and improved patient satisfaction.
Patient-Provider Conversations Regarding Financial Impact of Cancer Therapy Lacking
June 01, 2018Survey results presented at the 2018 ASCO Annual Meeting demonstrated the effects of financial toxicity on patients with early stage breast cancer.
Palliative care consultation linked to reduced direct hospital costs
May 22, 20181. In this meta-analysis of available studies, early palliative care consultation (PCC) for patients admitted to hospital with serious illness was associated with a reduction in direct hospital costs for that admission. 2. The reduction in direct hospital costs was greater for those patients with a cancer diagnosis and for those with 4 or more []
Benefits of Early Palliative Care for Cancer Extend Beyond Clinical Care
May 02, 2018A meta-analysis shows that earlier initiation of palliative care can effectively change patterns of care for patients with higher illness burden.
Breast Cancer Treatment-Related Financial Burden Greater for Black vs White Women
April 25, 2018In a study that evaluated outcomes for younger, working age women with breast cancer, researchers identified differences in cancer-related financial adverse events in black women vs white women.
SEE-ACBT Method Improves Postsurgical Outcomes in Lung Cancer Resection
April 04, 2018In a quasi-experimental pre-post study, researchers demonstrate the efficacy of the SEE-ACBT rehabilitation method on health-related and cost outcomes in patients with NSCLC who underwent curative lung resection.
Improved Access to Care Reported by Cancer Survivors
April 04, 2018In the 2010 to 2016 period, the proportion of survivors reporting delayed medical care decreased yearly.
Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
February 28, 2018At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.
Lower-Income Households Experienced Improved Health Costs After ACA Implementation
February 28, 2018The Affordable Care Act was linked to reduced cost burdens for middle to low-income households, study data indicate.
Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma
February 07, 2018Researchers report on their findings of a retrospective study that compared pomalidomide plus dexamethasone vs dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Better Postoperative Outcomes With RAMIE for Esophageal Cancer
January 18, 2018Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.
Ovarian Cancer Screening Potentially Cost-Effective in the United States
December 15, 2017Multimodal screening is more expensive, but reduces ovarian cancer mortality, researchers found.
Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden
December 12, 2017Recent study findings investigated the economic burden of patients with relapsed Ph-negative ALL, and the adverse events of special interest that are most likely to have the greatest impact. These findings were presented at ASH 2017.
Physical Examination Sufficient Work-up for Complaints of Breast Pain
December 08, 2017A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.
Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors
October 06, 2017A cross-sectional survey revealed the impact of symptoms and economic burden on quality of life for survivors of gastrointestinal cancer.
Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits
October 05, 2017Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.
Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
September 25, 2017Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).
Median Cost of Cancer Drug Development is Approximately $648 Million
September 12, 2017Total revenue from sales of 10 drugs was 67.0 billion, with total RD spending of 7.2 billion, researchers found.
Insured Patients with Cancer May Experience Financial Distress
August 11, 2017Cancer treatment is far costlier than expected, even for patients with cancer who have health insurance coverage, with being underinsured causing in the most distress for patients.
Poll: Many Seniors Struggling With Drug Costs Don't Seek Help
July 05, 2017Roughly half of older Americans experiencing difficulty paying for needed drugs did not talk to their physicians about the issue, poll shows.
Clinical Trials May Benefit Oncology Patients
June 22, 2017Research on the effects of research demonstrated that oncology-related clinical trials provide measurable benefits in terms
New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
June 21, 2017Doses May Be Adjusted for Treating NSCLC Patients
Can Biosimilars Help Achieve the Goals of US Health Care Reform?
June 16, 2017[Cancer Management and Research] This research examines the pros and cons of the Affordable Care Act enactment and the possible beneficial role biosimilars may play in this environment.
Sign Up for Free e-newsletters
ONA Articles
- Skin Cancer Screening Programs: Are They Effective?
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- Prophylactic Cranial Irradiation in Small-Cell Lung Cancer: Update on Patient Selection, Efficacy and Outcomes
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Skin Cancer Screening Programs: Are They Effective?
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Immune Checkpoint Inhibitors: A Review of Side Effects, Their Causes and Incidence
- ASCO Roundtable Addresses Clinical Trial Financial Burdens
- Cardiac Monitoring Advised for High-Risk Breast Cancer Patients
- United States Senate Passes Opioids Bill
- Estimating Quality of Life Based on Cumulative Drug Toxicity in Colorectal Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |